Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Guidant, J&J Agree To Arbitrate Suits, Exchange Licenses And Technology

This article was originally published in The Gray Sheet

Executive Summary

Guidant will evaluate in preclinical studies electronic field stimulation (EFS) technology gained through an agreement with Johnson & Johnson before deciding whether to incorporate it into its biventricular pacing device to treat congestive heart failure, the firm says.

You may also be interested in...



Optimizer III Targets Muscle Contractions To Treat Heart Failure; Enters Trial

Impulse Dynamics is 80% enrolled in the U.S. pivotal trial of its Optimizer III cardiac contractility modulation therapy for the treatment of heart failure

Optimizer III Targets Muscle Contractions To Treat Heart Failure; Enters Trial

Impulse Dynamics is 80% enrolled in the U.S. pivotal trial of its Optimizer III cardiac contractility modulation therapy for the treatment of heart failure

Guidant To Seek Review Of $425 Mil. Patent Suit Arbitration Award To Cordis

Guidant stent sales will not be affected by a June 5 arbitration panel finding that the firm infringed Johnson &Johnson/Cordis' Palmaz-Schatz patents, Guidant says

Related Content

UsernamePublicRestriction

Register

MT013218

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel